B cell depletion therapy in systemic lupus erythematosus (Q35216310)

7 August 2017

1 reference

title

B cell depletion therapy in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

7 August 2017

0 references

2

Iñaki Sanz

1 reference

7 August 2017

Jennifer Anolik

1

1 reference

PubMed ID

12967516

7 August 2017

R John Looney

series ordinal

3

1 reference

7 August 2017

1 October 2003

1 reference

Current Rheumatology Reports

7 August 2017

1 reference

7 August 2017

5

1 reference

7 August 2017

5

1 reference

7 August 2017

350-356

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-003-0020-x

7 August 2017

0 references

cites work

A critical role for B cells in the development of memory CD4 cells.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-003-0020-X

Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-003-0020-X

Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells

21 January 2018

1 reference

12 December 2020

Rituximab treatment results in impaired secondary humoral immune responsiveness.

1 reference

12 December 2020

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

1 reference

12 December 2020

Reduction in circulating dsDNA antibody titer after administration of LJP 394.

1 reference

12 December 2020

B cells process and present lupus autoantigens that initiate autoimmune T cell responses

1 reference

12 December 2020

Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease

1 reference

12 December 2020

Effective B cell depletion with rituximab in the treatment of autoimmune diseases

1 reference

12 December 2020

Rituximab: an insider's historical perspective.

1 reference

12 December 2020

Murine lupus genetics: lessons learned

1 reference

12 December 2020

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

1 reference

12 December 2020

Treatment of childhood autoimmune haemolytic anaemia with rituximab

1 reference

12 December 2020

From T to B and back again: positive feedback in systemic autoimmune disease

1 reference

12 December 2020

Quantitation of IgM- and IgG-secreting B cells in the peripheral blood of patients with systemic lupus erythematosus

1 reference

12 December 2020

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

1 reference

12 December 2020

An open study of B lymphocyte depletion in systemic lupus erythematosus

1 reference

12 December 2020

Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways

1 reference

12 December 2020

Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma

1 reference

12 December 2020

The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus

1 reference

12 December 2020

Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production

1 reference

12 December 2020

The role of B cells in lpr/lpr-induced autoimmunity

1 reference

12 December 2020

Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease

1 reference

12 December 2020

Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients

1 reference

12 December 2020

Murine lupus in the absence of alpha beta T cells

1 reference

12 December 2020

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

12 December 2020

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

1 reference

12 December 2020

Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.

1 reference

12 December 2020

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

12 December 2020

1 reference

12 December 2020

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

1 reference

12 December 2020

Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus

1 reference

12 December 2020

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

1 reference

12 December 2020

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

1 reference

12 December 2020

B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events

1 reference

12 December 2020

Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab).

1 reference

12 December 2020

Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab).

1 reference

12 December 2020

Cutting edge: B cells promote CD8+ T cell activation in MRL-Fas(lpr) mice independently of MHC class I antigen presentation

1 reference

12 December 2020

Therapeutic advances in systemic lupus erythematosus

1 reference

12 December 2020

CD20: a regulator of cell-cycle progression of B lymphocytes

1 reference

12 December 2020

Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity

1 reference

12 December 2020

Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus

1 reference

12 December 2020

Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus

1 reference

12 December 2020

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

1 reference

12 December 2020

B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation

1 reference

12 December 2020

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

12 December 2020

Treatment of murine lupus with monoclonal anti-T cell antibody

1 reference

12 December 2020

10.1007/S11926-003-0020-X

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12967516